BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1673954)

  • 1. [Effectiveness of neuro-electric therapy in drug resistant endogenous psychoses].
    Klimke A; Klieser E
    Fortschr Neurol Psychiatr; 1991 Feb; 59(2):53-9. PubMed ID: 1673954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up study of hysterical psychosis, reactive/psychogenic psychosis, and schizophrenia.
    Modestin J; Sonderegger P; Erni T
    Compr Psychiatry; 2001; 42(1):51-6. PubMed ID: 11154716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.
    Chanpattana W; Sackeim HA
    J ECT; 2010 Dec; 26(4):289-98. PubMed ID: 20375701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ECT the treatment of choice for first-break psychosis?
    Kellner CH
    Convuls Ther; 1995 Sep; 11(3):155-7. PubMed ID: 8528656
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
    Banov MD; Zarate CA; Tohen M; Scialabba D; Wines JD; Kolbrener M; Kim JW; Cole JO
    J Clin Psychiatry; 1994 Jul; 55(7):295-300. PubMed ID: 8071290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral ventricular size, psychopathology, and medication response in the psychoses.
    Luchins DJ; Lewine RR; Meltzer HY
    Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance ECT in treatment-resistant schizophrenia.
    Chanpattana W
    J Med Assoc Thai; 2000 Jun; 83(6):657-62. PubMed ID: 10932493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.
    Gaertner I; Gilot C; Heidrich P; Gaertner HJ
    Pharmacopsychiatry; 2002 Mar; 35(2):37-43. PubMed ID: 11951144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of electroconvulsive therapy in restrictive indications. A retrospective study of 15 years].
    Schott K; Bartels M; Heimann H; Buchkremer G
    Nervenarzt; 1992 Jul; 63(7):422-5. PubMed ID: 1501720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure activity in combined clozapine and ECT: a retrospective view.
    Cardwell BA; Nakai B
    Convuls Ther; 1995 Jun; 11(2):110-3. PubMed ID: 7552049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
    Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
    J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.